Regulatoriskt pressmeddelande2024-01-29 10:26Completion of the combination between Novozymes and Chr. Hansen
Regulatoriskt pressmeddelande2024-01-26 11:09All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen
Pressmeddelande2023-12-20 14:02Update on the merger approval process for the combination of Novozymes and Chr. Hansen: South Korean merger approval granted
Regulatoriskt pressmeddelande2023-12-19 10:54Major shareholder announcement from Burlington Loan Management DAC
Pressmeddelande2023-12-12 16:11Update on the merger approval process for the combination of Novozymes and Chr. Hansen: Conditional competition clearance from the European Commission obtained
Regulatoriskt pressmeddelande2023-11-20 07:03Update on the merger approval process for the combination of Novozymes and Chr. Hansen: The parties have submitted a remedy proposal to the European Commission.
Regulatoriskt pressmeddelande2023-10-10 06:08Novozymes announce the Executive Leadership Team and organizational structure for the future combined company of Novozymes and Chr. Hansen
Regulatoriskt pressmeddelande2023-09-27 07:23Major shareholder announcements from Burlington Loan Management DAC and Davidson Kempner Capital Management LP
Regulatoriskt pressmeddelande2023-09-04 09:48Update on the combination of Novozymes and Chr. Hansen: Chinese merger approval granted, supporting the path to completion
Regulatoriskt pressmeddelande2023-03-30 16:07Novozymes’ and Chr. Hansen’s shareholders approve combination to create a leading global biosolutions partner
Regulatoriskt pressmeddelande2023-03-30 15:57Resolutions passed at the Extraordinary General Meeting of Chr. Hansen Holding A/S
Regulatoriskt pressmeddelande2023-03-30 11:11Combination between Novozymes and Chr. Hansen approved by Novozymes’ shareholders
Regulatoriskt pressmeddelande2023-03-28 10:07Update on the combination of Novozymes and Chr. Hansen: U.S. antitrust regulation waiting period has expired, supporting the path to completion
Regulatoriskt pressmeddelande2023-03-08 07:00Publication of exemption document in relation to the proposed combination of Chr. Hansen and Novozymes, confirmation of outlook for 2022/23 and proposed candidates to the Board of Directors of the combined company